NectinTx
2 known investors
Nectin is a biotech developing a pipeline of targeted immunotherapies, including immuno-oncology antibodies and antibody-drug conjugates (ADCs). Its lead anti-PVR asset is in phase 1 clinical trials, addressing PVR expression as a rate-limiting factor for approved immune checkpoint inhibitors.
Investors · 2
Frequently asked questions
- What does NectinTx do?
- Nectin is a biotech developing a pipeline of targeted immunotherapies, including immuno-oncology antibodies and antibody-drug conjugates (ADCs). Its lead anti-PVR asset is in phase 1 clinical trials, addressing PVR expression as a rate-limiting factor for approved immune checkpoint inhibitors.
- Who are NectinTx's investors?
- NectinTx's investors include Israel Biotech Fund, Peregrine Ventures.